DAEWOONG PHARMACEUTICAL HITS UPON ORAL FORMULATION –FOISTAR AGAINST COVID-19

• Daewoong Pharmaceutical announced on Nov. 23 that it has finished with assimilating patients for a second-phase clinical test of Foistar Tablet being developed as a COVID-19 treatment.
• The clinical trial will be spearheaded by Oh Myung-don, an infectious medicine professor at Seoul National University.

Expressing gratitude to researchers who helped in patient recruitment, Oh said he would speed up the clini....